About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
T
Diabetes Complications: Q&A / Panel Discussion
By
Practical Ways to Achieve Targets in Diabetes Care
FEATURING
Todd Brusko
,
John Buse
,
Sandip Garg
,
Steven Nissen
,
Marian Rewers
By
Practical Ways to Achieve Targets in Diabetes Care
FEATURING
Todd Brusko
,
John Buse
,
Sandip Garg
,
Steven Nissen
,
Marian Rewers
133 views
August 23, 2023
0 Comments
Login to view comments.
Click here to Login
Featured Video
18:06
Lilly Obesity
Getting Patients Started with an Obesity Treatment Option for Adults
Feat.
E. Lazarus
Featured Video
18:06
Lilly Obesity
Getting Patients Started with an Obesity Treatment Option for Adults
Feat.
E. Lazarus
Related Content
AUTOPLAY
ON
47:11
Houston Methodist Hospital
The Protein Myth: Our Obsession With Protein and How It Is Killing US
Feat.
G. Davis
49:21
Physicians Committee for Responsible Medicine
Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…
Feat.
T. J. Key
34:49
Scripps Health
Medications for Weight Loss: The New Satiety Hormones
Feat.
K. Fujioka
23:35
Practical Ways to Achieve Targets in Diabetes Care
Is There a Future for HbA1c? (Moving Towards CGM: GMI and TIR)
Feat.
I. Hirsch
15:06
Robert Busch
GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!
26:01
Cardiology Fiesta 2017
Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…
Feat.
R. DeFronzo
37:21
University of Colorado Department of Medicine
Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…
Feat.
R. Johnson
12:26
Juan Frias
SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide
15:33
Ken Fujioka
Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…
17:44
Rita Jermyn
SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease
26:32
Practical Ways to Achieve Targets in Diabetes Care
Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity
Feat.
S. Nissen
20:24
Diana Isaacs
Tirzepatide for Type 2 Diabetes
44:41
Norman Lepor
Obesity: New Understanding and Treatments
19:26
Krista Varady
ADA 2022 Flipping the Metabolic Switch: Intermittent Fasting as a We…
26:49
Diana Isaacs
Tirzepatide Updates
23:21
Practical Ways to Achieve Targets in Diabetes Care
TIR vs. A1c: Q&A/ Panel Discussion
Feat.
J. Skyler,
G. Aleppo,
T. Danne,
L. Barbour
05:08
Susan Brian
The Differences Between the Products of GLP1's and GLP/GIPs
06:31
Susan Brian
Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist
44:43
Jason Fung
Type 2 Diabetes Aetiology and Reversibility
18:49
INOVA
Home Ultrasound: Revolutionaizing Antenatal Management
Feat.
A. Wiznitzer